• 22. Januar 2025

Anergis Announces Completion of Treatment in AllerT Phase II Dose-Ranging Trial

ByAnergis SA

Apr. 1, 2015
#8722 213 patients included in trial of novel ultra-fast allergy immunotherapeutic
Teile den Beitrag mit Freunden

Kommentar verfassen